药物分子对羟丙基-β-环糊精复合包合物的影响

来源 :中国中药杂志 | 被引量 : 0次 | 上传用户:qiang5656
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
研究不同性质药物葛根素、冰片、梓醇两两包合时的相互影响,探索多组分、多性质的中药复方包合物的包合规律。以HP-β-CD作为包合材料,冷冻干燥法制备包合物。通过包合量测定、DSC和X射线衍射考察葛根素、冰片、梓醇两两包合时的包合情况。结果显示,难溶性药物葛根素和冰片同时包合,当葛根素过量时,葛根素的包合量与单独包合时无明显差异,冰片未被包合;当葛根素量不足而HP-β-CD过量时,冰片才被包合,且包合量低于冰片单独包合。水溶性药物梓醇与葛根素或冰片共同包合时,葛根素或冰片的包合量与单独包合时无明显差异,DSC和X射线衍射图谱均无梓醇的特征峰。难溶性药物葛根素和冰片同时包合时存在竞争,葛根素竞争性更强。水溶性药物梓醇能与HP-β-CD复合但不影响葛根素和冰片的包合。 To study the interaction between puerarin, borneol and catalpol with different properties, and to explore the inclusion law of multi-component and multi-component traditional Chinese medicine inclusion compounds. Using HP-β-CD as the inclusion material, the inclusion compound was prepared by freeze-drying method. The inclusions of puerarin, borneol and catalpol were observed by inclusion amount determination, DSC and X-ray diffraction. The results showed that the insoluble drug puerarin and borneol inclusion at the same time, when the puerarin is excessive, the amount of puerarin inclusion and inclusion alone was no significant difference, borneol was not included; when the amount of puerarin and HP- -CD overdose, borneol was only inclusion, and the inclusion amount is lower than borneol alone inclusion. When the water-soluble drug catalpol and puerarin or borneol were combined together, there was no significant difference between the inclusion amount of puerarin or borneol and that of inclusion alone. There was no characteristic peak of catalpol in DSC and X-ray diffraction patterns. There is competition between the insoluble drug puerarin and borneol, and the puerarin is more competitive. The water-soluble drug catalpol can complex with HP-β-CD but does not affect the inclusion of puerarin and borneol.
其他文献
目的研究鼠因子Ⅶ(mfⅦ)与金黄色葡萄球菌肠毒素A(SEA)融合蛋白的抗肿瘤生长和转移活性。方法构建表达Ⅶ冈子-SEA融合蛋白的腺病毒载体,用293包装细胞系制备病毒Ad/mfⅦ-SEA。局部荧光检测证明其表达能力和安全性后,直接应用病毒感染的293细胞以皮下注射的方式进行试验。采用小鼠205H12肺转移模型和小鼠RM-1皮下肿瘤模型检测mfⅦ-SEA对小鼠皮下肿瘤生长和肺转移形成的抑制情况。结果